Who Exports Itraconazole from India — 285 Suppliers Behind a $27.4M Market
India's itraconazole export market is supplied by 285 active exporters who collectively shipped $27.4M across 2,727 shipments. COHANCE LIFESCIENCES LIMITED leads with a 13.4% market share, followed by ANNORA PHARMA PRIVATE LIMITED and CAPLIN POINT LABORATORIES LIMITED. The top 5 suppliers together control 54.9% of total export value, reflecting a moderately competitive market structure.
Top Itraconazole Exporters from India — Ranked by Export Value
COHANCE LIFESCIENCES LIMITED is the leading itraconazole exporter from India, holding a 13.4% share of the $27.4M market across 2,727 shipments from 285 exporters. The top 5 suppliers — COHANCE LIFESCIENCES LIMITED, ANNORA PHARMA PRIVATE LIMITED, CAPLIN POINT LABORATORIES LIMITED, MICRO LABS LIMITED, ALKEM LABORATORIES LIMITED — collectively control 54.9% of total export value, indicating a moderately concentrated market. Individual shares are: COHANCE LIFESCIENCES LIMITED (13.4%), ANNORA PHARMA PRIVATE LIMITED (12.5%), CAPLIN POINT LABORATORIES LIMITED (11.0%), MICRO LABS LIMITED (9.5%), ALKEM LABORATORIES LIMITED (8.5%).
Top Itraconazole Exporters from India
Ranked by export value · 285 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | COHANCE LIFESCIENCES LIMITED ITRACONAZOLE IR PELLETS 22%ITRACONAZOLE IR PELLETS 22% W/WITRACONAZOLE CAPSULES 100MG | $3.7M | 5 | 13.4% |
| 2 | ANNORA PHARMA PRIVATE LIMITED ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $3.4M | 1 | 12.5% |
| 3 | CAPLIN POINT LABORATORIES LIMITED ITRACONAZOLE CAPSULES 100MGITRACONAZOLE PELLETS 22% W/WITRACOREN | $3.0M | 3 | 11.0% |
| 4 | MICRO LABS LIMITED ITRACON ITRACONAZOLE CAPSULES 100MG 5X10SITRACON CAPSULES [PHARMACEUTICAL PRODUCTS: (ITRACONAZOLE 1 | $2.6M | 11 | 9.5% |
| 5 | ALKEM LABORATORIES LIMITED ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $2.3M | 3 | 8.5% |
| 6 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $2.1M | 1 | 7.8% |
| 7 | INTAS PHARMACEUTICALS LIMITED PH.DRU.& MED.: ITRACONAZOLE CAPSULES 100 | $1.4M | 1 | 5.1% |
| 8 | RA CHEM PHARMA LIMITED ITRACONAZOLE CAPSULES 100MGITRACONAZOLE SOLUTIONITRACONAZOLE IR PELLETS 22% | $1.4M | 6 | 5.0% |
| 9 | TORRENT PHARMACEUTICALS LTD ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $932.6K | 3 | 3.4% |
| 10 | ALEMBIC PHARMACEUTICALS LIMITED ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $804.4K | 1 | 2.9% |
| 11 | KUSUM HEALTHCARE PRIVATE LIMITED PHARMACEUTICAL PRODUCTS: (ITRACONAZOLE 1RAXNAZOLE | $701.4K | 5 | 2.6% |
| 12 | AJANTA PHARMA LIMITED | $609.0K | 1 | 2.2% |
| 13 | YASH PHARMACEUTICALS ITRACONAZOLE 100MG HARD GELATINE CAPSULES | $524.2K | 1 | 1.9% |
| 14 | SAGA LIFESCIENCES LIMITED PHARMACEUTICAL PRODUCTS: (ITRACONAZOLE 1RAXNAZOLE | $474.6K | 7 | 1.7% |
| 15 | MANKIND PHARMA LIMITED ITRACONAZOLE 100MG HARD GELATINE CAPSULES | $418.1K | 4 | 1.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Itraconazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Cohance Lifesciences Limited | Warning Letter, January 2 | Unknown | Unknown | Not verified | Received FDA warning letter for CGMP violations at Hyderabad facility. |
| Annora Pharma Private Limited | Approved | Unknown | Unknown | 1 | Received FDA approval for Indomethacin Suppositories USP, 50 mg, in July 2025. |
| Torrent Pharmaceuticals Ltd | Approved | Yes | Yes | 1 | Holds FDA approval for Prucalopride Tablets, 1 mg and 2 mg, as of June 2025; WHO |
| Alembic Pharmaceuticals Limited | Approved | Yes | Yes | 223 | Received multiple FDA approvals between 2024 and 2025; WHO-GMP and EU GMP certif |
| Intas Pharmaceuticals Limited | Approved | Yes | Yes | 89 | Holds FDA approvals and is WHO-GMP and EU GMP certified. |
TransData Nexus reviewed the regulatory standing of 5 leading Itraconazole exporters from India. 4 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Itraconazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players like Aurobindo Pharma, Bharat Biotech, and Dr. Reddy’s Laboratories. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a hub for pharmaceutical research and manufacturing.
The Telangana government's initiatives, such as the Hyderabad Pharma City project, aim to create the world's largest integrated pharmaceutical hub, fostering innovation and investment in the sector.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant center for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907.
The region's robust infrastructure and skilled workforce have attracted numerous pharmaceutical companies, making it a key player in both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region hosts several pharmaceutical companies, leveraging its strategic location and well-developed logistics infrastructure to streamline export operations.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units, contributing significantly to the production of various pharmaceutical products, including Itraconazole.
5Sourcing Recommendations
- Diversify Supplier Base: While the top five exporters account for a significant portion of Itraconazole exports, engaging with a broader range of suppliers can mitigate risks associated with supply chain disruptions.
- Leverage Regional Strengths: Utilize Hyderabad's bulk drug manufacturing capabilities and the Ahmedabad-Vadodara region's expertise in formulations to optimize sourcing strategies.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and facilitate smooth market entry.
- Evaluate Logistics Infrastructure: Assess the logistics and export capabilities of regions like Mumbai-Thane-Raigad to ensure efficient and cost-effective distribution channels.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Itraconazole exporters from India
Suven Pharmaceuticals Limited and Cohance Lifesciences Limited — Suven and Cohance merge to form a leading CDMO platform
In September 2025, Suven Pharmaceuticals and Cohance Lifesciences completed an all-share merger to establish a consolidated Contract Development and Manufacturing Organization (CDMO). This strategic move aims to enhance their combined capabilities in active pharmaceutical ingredients (APIs) and small molecule development, expanding their customer base across North America, Europe, and India. - IMPACT: The merger is expected to strengthen the companies' positions in the Itraconazole export market by leveraging combined resources and expanded market reach.
Impact: The merger is expected to strengthen the companies' positions in the Itraconazole export market by leveraging combined resources and expanded market reach.
Cohance Lifesciences Limited — Cohance completes US FDA audit at Ankleshwar site
In April 2023, Cohance Lifesciences successfully completed a US FDA audit at its Ankleshwar facility, demonstrating compliance with regulatory standards. - IMPACT: This approval enhances Cohance's credibility and may facilitate increased Itraconazole exports to the United States.
Impact: This approval enhances Cohance's credibility and may facilitate increased Itraconazole exports to the United States.
Cohance Lifesciences Limited — Cohance secures EU GMP certification for Atchutapuram site
In May 2023, Cohance Lifesciences obtained EU Good Manufacturing Practice (GMP) certification for its Atchutapuram facility, affirming adherence to European quality standards. - IMPACT: This certification is likely to boost Itraconazole exports to European markets by ensuring compliance with EU regulations.
Impact: This certification is likely to boost Itraconazole exports to European markets by ensuring compliance with EU regulations.
Common Questions — Itraconazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which itraconazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, COHANCE LIFESCIENCES LIMITED leads with 69 recorded shipments worth $3.7M. ANNORA PHARMA PRIVATE LIMITED (27 shipments) and CAPLIN POINT LABORATORIES LIMITED (10 shipments) are also established high-volume exporters.
Q How many itraconazole manufacturers are there in India?
India has 285 active itraconazole exporters with a combined export market of $27.4M across 2,727 shipments to 123 countries. The top 5 suppliers hold 54.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for itraconazole from India?
Average FOB unit price: $9.47 per unit, ranging from $0.01 to $1383.80. Average shipment value: $10.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 285 verified Indian exporters of Itraconazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,727 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 123 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,727 Verified Shipments
285 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists